Institutional investors purchased a net $430.4 thousand shares of VTVT during the quarter ended June 2019. This may signal that the smart money is gaining interest in this company as the 7.23% of the shares outstanding that institutional investors hold is among the lowest in the Biotechnology industry.
Mutual fund holders
Largest Quarterly Institutional Transactions
Latest Institutional Activity
THE VANGUARD GROUP, INC. Bought 971.7 Thousand shares of vTv Therapeutics Inc